Riskpilot← Back to searchSign inGet full accessGBG Aeromedical AB
ABActiveOrg 5568863004Norra Gubberogatan 30General medical practice activities · NACE 8621Est. 20123 employees
Revenue 2024
SEK 4,1M
-9% vs 2023
EBITDA margin
5.3%
+20% vs 2023
Equity ratio
55.0%
Financial strength
Net profit 2024
SEK 263K
+84% vs 2023
| Revenue | SEK 4,1M | -9% |
| EBITDA | SEK 219K | +20% |
| Net profit | SEK 263K | +84% |
| Total assets | SEK 1,7M | -9% |
| Equity | SEK 929K | +39% |
| Employees | 3 | — |
Legal name
GBG Aeromedical AB
Org number
5568863004
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 mars 2012
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva flyg- och allmänmedicinsk läkarverksamhet, tillhandahålla medicinska tjänster, utbildning och därmed förenlig verksamhet.
Address
Norra Gubberogatan 30
Phone
+46707953345
Email
jakob@flyglakare.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 941 | 3 933 | 4 809 | 4 509 | 4 124 |
| Staff expenses | — | — | −1 860 | −2 083 | −1 478 |
| EBITDA | −427 | 341 | 581 | 183 | 219 |
| Depreciation & amort. | −0 | −0 | — | — | −7 |
| EBIT | −427 | 341 | 581 | 183 | 212 |
| Net financials | −1 | −2 | −1 | −1 | −0 |
| Profit before tax | −427 | 339 | 460 | 182 | 332 |
| Tax | −0 | −0 | −79 | −39 | −70 |
| Net profit | −427 | 339 | 380 | 142 | 263 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 080 | 1 417 | 1 531 | 1 862 | 1 689 |
| Equity | 105 | 444 | 524 | 667 | 929 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 975 | 973 | 887 | 1 075 | 760 |
| Total debt | 975 | 973 | 887 | 1 075 | 760 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
55.0%
This company
38.2%
Market median
+44% vs market
20202024
Return on equity
28.3%
This company
18.4%
Market median
+54% vs market
20202024
Net profit margin
6.4%
This company
8.1%
Market median
-21% vs market
20202024
Asset turnover
2.44×
This company
1.12×
Market median
+118% vs market
20202024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KG Auditor Substitute | Auditor Substitute | 2024 |
HM | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GBG Aeromedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kerstin Gunilla Svedberg | Auditor Substitute | 0 companies |
| Heléne Margareta Ekman | Audit | 0 companies |
| Carl Daniel Wennroth | Deputy Board Member | 0 companies |
| Carl Jakob Christoffer Borkmann | Board of Directors | 0 companies |